Skip to main content

News & Press Releases

Filter by:

Ellyn Sternfield, a Mintz Special Counsel, is quoted in this Bloomberg BNA Health Care Daily Report article on claims by congressional Republicans that Medicaid’s classification of EpiPens as “generic” lowered company rebates paid to the program.
Mintz has named Adam L. Sisitsky Co-Chair of the firm’s Securities Litigation Practice. Mr. Sisitsky will serve along with current Co-Chair, John F. Sylvia.
Six Mintz Members will speak at the 2016 International Bar Association Conference. The Members are Robert I. Bodian, Richard R. Kelly, Heidi A. Lawson, Bruce D. Sokler, Stephen M. Weiner, and Laura Bange Stephens.
Mintz attorneys successfully represented adidas America Inc. in arguing against certification of a class action suit involving one of the company’s popular running shoes. The U.S. District Judge ruled the plaintiff did not present sufficient evidence that adidas’ Springblade shoes were defective.  
Jeremy D. Glaser, Co-Chair of the Mintz Venture Capital & Emerging Companies Practice, is moderating a panel discussion at ACG San Diego’s “What’s Brewing in the Craft Beer & Distilled Spirits Space – Trends and Updates” program.
ML Strategies Executive VP & Director of Operations Alex Hecht and Manager of Government Relations Eli Greenspan authored this HFMA Advisor article discussing the impact that states transitioning their Medicaid populations into managed care has had on individuals with traumatic brain injuries.
Kerri Chace headshot
Press Contact

Kerri Chace

Associate Director, Communications

[email protected]
|
1.617.348.1671

Follow Mintz